Reardon Tighe (CIK 0001760431)

Latest company ownership

Shares held
172,935
Last filed at
Jun 10, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 3, 2024 Jun 5, 2024 Janux Therapeutics, Inc. CFO Sell 15.0 -822,721 -16.55% $45M
Nov 13, 2023 Nov 15, 2023 Janux Therapeutics, Inc. CFO Buy 100.0 +849,854 100.00% $5M
Jun 15, 2021 Jun 16, 2021 Janux Therapeutics, Inc. CFO Buy 100.0 +629,411 15.65% $10.7M